Skip to content

BBL

by Becton, Dickinson and Company 76 variants

Ref 231749

BBL (231749) is a beta-lactamase detection reagent IVD (EU IVDR Class A; FDA Class I; FDA product code JTO, Discs, Strips and Reagents, Microorganism Differentiation) made by Becton, Dickinson and Company, registered in EUDAMED on 9 Apr 2026 (Basic UDI-DI 038290EWFBUOBKA6) and listed in FDA GUDID since 25 May 2018 (UDI-DI 30382902317495), active as of 26 Oct 2026.

Active European Union. Also listed in GUDID (US).

CE IVDR

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None, self-declared

Class I: no certifier involved

Trust

Unverified

Source EUDAMED, GUDID, synced 26 Oct 2026.

Regulatory status

as of registry sync 26 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR EUDAMED Number038290EWFBUOBKA6 Basic UDI-DI 30382902317495UDI-DIDate9 Apr 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number30382902317495 UDI-DI Date25 May 2018ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
BD BBL™ Dryslide™ Nitrocefin
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 30 May 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI 038290EWFBUOBKA6 registered 9 Apr 2026 Active
  • FDA GUDID UDI-DI 30382902317495 listed 25 May 2018 Listed

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Timeline

2 dated events

  1. Listed FDA GUDID 30382902317495
  2. Registered EUDAMED 038290EWFBUOBKA6

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDR Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Trade name
Bbl EUDAMED
BD BBL™ Dryslide™ Nitrocefin GUDID
Generic name
Beta-lactamase detection reagent IVD
Model / Ref / Catalog
231749
Primary DI / UDI-DI
30382902317495
Basic UDI-DI
038290EWFBUOBKA6
Unit of use DI
00382902317494
FDA product code
JTO
EMDN code
W0104080299 Manual identification - other
GMDN term
Beta-lactamase detection reagent IVD
Device class
Class A EUDAMED
Class I GUDID
Regulation number
866.2660
EU registration type
Standard device
EU market of registration
Belgium
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class A
GUDID
Class I

Device class is stated on each registry's own scale: Class A in the EU (EUDAMED), Class I in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Manufacturer details

EUDAMED SRN
US-MF-000018910
Authorised representative
Becton Dickinson Ireland Limited IE-AR-000007610

Similar devices in this category

Other devices filed under MANUAL IDENTIFICATION - OTHER.

Other devices from Becton, Dickinson and Company

See all devices from Becton, Dickinson and Company →

Properties

  • Single use
  • Reagent
  • Professional testing
  • Prescription use
  • Lot / batch number
  • Expiration date
Other properties (20, all answered No)